Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INDINAVIR vs INFLIXIMAB, RECOMBINANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

INDINAVIR vs INFLIXIMAB, RECOMBINANT: Safety Overview

Metric INDINAVIR INFLIXIMAB, RECOMBINANT
Total FAERS Reports 728 255
Deaths Reported 15 16
Death Rate 2.1% 6.3%
Hospitalizations 114 93
Average Patient Age 45.2 yrs 44.2 yrs
% Female Patients 29.9% N/A
FDA Approval Date Apr 19, 2000 N/A
Marketing Status Discontinued N/A